Lab
New Vision Medical Diagnostics INC
New Vision Medical Diagnostics INC was paid $1.94M by Medicaid between Jan 2018 and Jul 2024, across 56 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 12% of everything it billed.
33Billing provider infoNEW VISION MEDICAL DIAGNOSTICS INC
BAYAMON, PR 00959
BAYAMON, PR 00959
33aNPI1912252826assigned 07/17/2012
33bProvider typeClinical Medical Laboratory
28Total paid$1.94M
24GClaims150,558
24DCodes billed56
24AFirst – last monthJan 2018 – Jul 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#51 of 777
Median peer was paid$278K
This provider vs. median7.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 29,661 | $425K | |
| 2019 | 27,502 | $247K | |
| 2020 | 18,502 | $235K | |
| 2021 | 19,898 | $256K | |
| 2022 | 21,482 | $309K | |
| 2023 | 21,917 | $306K | |
| 2024incomplete | 11,596 | $159K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 84443 | Thyroid stimulating hormone (TSH) | 12% | 14,300 | 13,482 | $241K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 9.7% | 7,840 | 7,513 | $187K |
| 80061 | Lipid panel | 9.5% | 13,428 | 12,695 | $184K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 9.1% | 22,321 | 20,546 | $176K |
| 80053 | Comprehensive metabolic panel | 8.2% | 14,805 | 13,914 | $158K |
| 80074 | 5.3% | 2,099 | 1,990 | $102K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 4.9% | 2,203 | 2,082 | $95K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.8% | 1,930 | 1,836 | $93K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.1% | 7,961 | 7,601 | $79K |
| 82274 | 3.5% | 4,838 | 4,248 | $69K | |
| 84439 | 3.2% | 6,580 | 6,204 | $63K | |
| 87400 | 3.2% | 3,562 | 3,379 | $62K |
44 more codes
| 82607 | 3.1% | 3,819 | $61K | |
| 81001 | 2.7% | 15,736 | $53K | |
| 86738 | 2.4% | 3,189 | $47K | |
| 84153 | 2.2% | 2,202 | $43K | |
| 86703 | 2.1% | 3,276 | $41K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.4% | 753 | $28K |
| 87110 | <1% | 848 | $16K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,908 | $16K |
| 86328 | <1% | 810 | $15K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 393 | $15K |
| 82043 | <1% | 2,344 | $14K | |
| 86803 | <1% | 871 | $13K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,340 | $11K |
| 84479 | <1% | 1,964 | $9K | |
| 84436 | <1% | 1,323 | $8K | |
| 82570 | <1% | 1,361 | $7K | |
| 85651 | <1% | 1,635 | $6K | |
| 86592 | <1% | 1,398 | $6K | |
| 85730 | <1% | 514 | $3K | |
| 85610 | <1% | 643 | $3K | |
| 86140 | <1% | 416 | $2K | |
| 80050 | General health panel | <1% | 126 | $1K |
| 83970 | <1% | 30 | $1K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 40 | $1K |
| 82951 | <1% | 64 | $986.29 | |
| 87109 | <1% | 186 | $959.01 | |
| 84156 | <1% | 234 | $926.57 | |
| 80069 | <1% | 91 | $769.08 | |
| 86376 | <1% | 56 | $741.30 | |
| 86038 | <1% | 52 | $660.66 | |
| 86430 | <1% | 118 | $627.49 | |
| 82952 | <1% | 64 | $603.46 | |
| 82728 | <1% | 39 | $538.58 | |
| 83655 | <1% | 47 | $527.60 | |
| 84550 | <1% | 53 | $245.05 | |
| 86800 | <1% | 14 | $230.49 | |
| 84132 | <1% | 515 | $211.90 | |
| 82947 | <1% | 87 | $175.03 | |
| 87070 | <1% | 13 | $116.62 | |
| 80076 | <1% | 32 | $109.94 | |
| 84100 | <1% | 35 | $67.36 | |
| 86696 | <1% | 12 | $16.73 | |
| 82248 | <1% | 28 | $16.32 | |
| 86695 | <1% | 12 | $11.40 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVARGAS RODRIGUEZ, JOSE (PRESIDENT)
Parent organization1659503795
| Provider | Location | Paid |
|---|---|---|
| Varmed Health Center LLC | Bayamon, PR | $307K |
| New Vision Medical Diagnostics LLC | Bayamon, PR | $304K |
| Medical Network LLC | Bayamon, PR | $5K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.